Main Article Content
Session Description: “The rights, safety, and well-being of subjects participating in clinical trials are most important considerations [E6 (R2) Good Clinical Practice]”. The objective of this session is to discuss the value proposition of blockchain technology for various stakeholders in the complex clinical trial ecosystem, barriers that limit the adoption of blockchain technology in clinical trials, and opportunities to overcome those challenges.
Thank you , Bronze Sponsor, Boehringer Ingelheim
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Blockchain in Healthcare Today (BHTY).